Expected Outcome:
Successful proposals will contribute to the updated EU Bioeconomy Strategy, Farm to Fork Strategy, the Horizon Europe Mission ‘A Soil Deal for Europe’, in particular the objectives: ‘Reduce soil pollution and enhance restoration’, the European Chemical Industry Action Plan as well as the Clean Industrial Deal.
Projects results are expected to contribute to the following expected outcomes:
Scope:
FAO estimates that up to 40% of food crops are lost due to plant pests and diseases globally every year.[1] Chemical synthetic products are conventionally used to protect crops and other plants from pests and diseases. In parallel, the EU is largely dependent on imports of both mineral and chemical fertilisers to grow crops. In both cases, over-use of synthetic/mineral products also poses concern for soil health and food quality. Moreover, the unequal distribution and depletion of non-renewable sources risks disrupting supply chains, particularly during energy crises.
SSbD bio-based fertilising and crop protection products can offer more resilient and sustainable solutions creating an added-value partnership between agriculture and industry both upstream (for feedstock supply) and downstream (for the use of sustainable and efficient bio-based products). However, when scaling-up, challenges need to be solved in terms of process efficiency and robustness against feedstock variability, formulations stability and efficacy on the field (also in consideration of climate change effects and different soil conditions), and cost competitiveness.
Proposals under this topic should:
In addition to the specific requirements applicable for the type of action, as described in section 2.2.3.1 of the CBE JU Annual Work Programme 2026[2], proposals under this topic should:
All Horizon Europe proposals are scored on three decisive pillars:
✔️ Excellence
✔️ Impact (most decisive in practice)
✔️ Quality & Efficiency of Implementation
👉 Proposals must meet minimum thresholds (≈10/15 total) and ≥3 per criterion to be fundable
From large-scale studies of EU Framework grants:
Key factors:
Structural advantages:
👉 This is one of the most consistently proven predictors across studies
Successful proposals often show:
👉 “Triangular collaboration” (academia + industry + research orgs) is common in funded projects
👉 Misalignment is a major reason for rejection (even for strong science)
Critical but often underestimated predictors:
👉 Administrative errors can lead to automatic rejection
👉 Weak or inflated budgets reduce evaluation scores
👉 Studies show success depends on both:
👉 Meaning: even strong proposals fail → optimization of all predictors is essential
Highest impact factors:
Moderate but critical:
4. Implementation quality
5. Call alignment
6. Budget credibility
Supporting factors:
7. Proposal writing quality & compliance
8. Early preparation
9. Familiarity with EU evaluation process
The biggest shift from Horizon 2020 → Horizon Europe is:
👉 Impact is now as important (or more) than scientific excellence
General conditions
1. Admissibility conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligibility Conditions
described in Annex B of the Work Programme General Annexes.
Sponsor Institute/Organizations: European Commission
Sponsor Type: Government/Federal
Address: Berlaymont Building, Rue de la Loi 200, 1040 Brussels
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 22, 2026
Sep 22, 2026
$20,000,000
Affiliation: European Commission
Address: Berlaymont Building, Rue de la Loi 200, 1040 Brussels
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.